Atara Biotherapeutics Inc —— 资产负债表 (NASDAQ:ATRA) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 588.12 M468.13 M376.42 M165.5 M109.1 M20.23 M 负债总额 125.78 M188.51 M249.78 M264.74 M206.38 M58.74 M 权益总额 462.34 M279.61 M126.64 M-99.23 M-97.28 M-38.5 M 负债及股东权益总额 588.12 M468.13 M376.42 M165.5 M109.1 M20.23 M 总债务 —————— 净债务 ——————

新闻

Atara schedules FDA meeting on tabelecleucel license application

Pierre Fabre requests FDA meeting on tabelecleucel approval

Atara extends $9M milestone payment deadline to 2028

Atara Bio董事黄杰姆出售价值48.9万美元股份

Atara Bio director Huang James sells $489k in shares

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.17%

美国股市上涨；截至收盘道琼斯工业平均指数上涨0.17%

FDA出人意料地拒绝Atara的tabelecleucel申请

FDA rejects Atara’s tabelecleucel application in surprise reversal

Atara Biotherapeutics stock plunges after FDA rejects cancer therapy

Gold Rises Sharply; Lyra Therapeutics Shares Plunge - Atara Biotherapeutics (NASDAQ:ATRA), Day One Biopharmaceutical (NASDAQ:DAWN)

Why Is Atara Biotherapeutics Stock Sinking Monday? - Atara Biotherapeutics (NASDAQ:ATRA)